further 18 h at room temperature in the dark, the mixture was
carefully washed with 3 M HCl (3 Â 25 cm3), saturated aqu-
eous sodium hydrogencarbonate (3 Â 25 cm3) and finally with
water (25 cm3). The organic phase was dried over MgSO4 ,
evaporated and the residue purified by column chromato-
graphy (silica gel, acetate–dichloromethane, 1 : 2 v=v). A small
amount of unreacted oxazoline eluted first, followed by the
major band of the product. Evaporation and drying in vacuo (2
Torr, 80 ꢁC, 1 h) afforded pure (S,Sp)-2 as an orange solid
(note: orange glassy material that crystallizes upon standing
was obtained in several cases). Yield: 0.381 g, 70%.
vNH 3244 (m), 3214 (m); ester vC O 1710 (vs), amide I 1674 (vs),
=
20
amide II 1558 (br, m). [a]D ¼ ꢀ96.1ꢁ (c ¼ 1.0, CHCl3). Anal.
calcd. for C30H32FeNO4P: C, 64.64; H, 5.79; N, 2.51%.
Found: C, 64.88; H, 5.68; N, 2.55%.
(Sp)-2-(Diphenylphosphino)ferrocenecarboxylic acid, (Sp)-
Hpfc. Ester amide (S,Sp)-2 (271 mg, 0.50 mmol) was dissolved
in a mixture of THF (5 cm3) and methanol (5 cm3). An aqu-
eous 3 M sodium hydroxide solution (5 cm3, 15 mmol) was
added and the resulting orange solution was stirred at 50 ꢁC
overnight. The organic solvents were removed under reduced
pressure, the residue was acidified with aqueous 3 M HCl and
extracted with dichloromethane (3 Â 10 cm3). The combined
organic extracts were washed with water (2 Â 25 ml), dried
(MgSO4) and evaporated. The residue was purified by chro-
matography on silica gel using a dichloromethane-methanol
(20 : 1, v=v) mixture as the eluent. A small amount of methyl
(Sp)-2-(diphenylphosphino)ferrocenecarboxylate is eluted first
(ca. 7 mg, 3%; identified by NMR), followed by the product,
which was obtained after evaporation and drying in vacuo
(1 Torr, 60 ꢁC, 1 h) as a bright orange solid (192 mg, 93%).
1H NMR (CDCl3): d 3.79 (ddd, J ꢂ 2.6, 1.4, 0.9 Hz, 1 H,
C5H3 , H-3), 4.24 (s, 5 H, C5H5), 4.49 (ddd, J ꢂ 2.6, 2.6, 0.6 Hz,
1 H, C5H3 , H-4), 5.09 (ddd, J ꢂ 2.6, 1.5, 1.4 Hz, 1 H, C5H3 ,
H-5), 7.19–7.54 (m, 10 H, PPh2). 13C{1H} NMR (CDCl3): d
71.27 (d, J ¼ 1.2 Hz, C5H5), 72.44 (C5H3 , C-4), 74.06 (d,
1JPC ¼ 15.9 Hz, C5H3 , C-2), 74.8 (C5H3 , C-5), 75.82 (d,
2JPC ¼ 4.9 Hz, C5H3 , C-3), 76.99 (d, 2JPC ¼ 15.9 Hz, C5H3 , C-
3
1H NMR (CDCl3): d 0.97 (d, JHH ¼ 6.7 Hz, 3 H, CHMe2),
3
1.06 (d, JHH ¼ 6.6 Hz, 3 H, CHMe2), 1.72 (s, 3 H, MeCO),
2.03–2.18 (m, 1 H, CHMe2), 3.71 (ddd, J ꢂ 2.6, 1.5, 1.0 Hz, 1
3
2
H, C5H3 , H-3), 3.83 (dd, JHH ¼ 3.0, JHH ¼ 11.2 Hz, 1 H,
3
CH2O), 3.88 [dddd, 3JHH ꢂ JHH ꢂ 8 (NH, CHMe2),
3
3JHH ꢂ JHH ꢂ 3 Hz (CH2), 1 H, CHNH], 4.18 (s, 5 H, C5H5),
4.51 (ddd, J ꢂ 2.6, 2.6, 0.6 Hz, 1 H, C5H3 , H-4), 4.62 (dd,
2
3JHH ¼ 3.0, JHH ¼ 11.3 Hz, 1 H, CH2O), 5.19 (ddd, J ꢂ 2.6,
1.5, 1.3 Hz, 1 H, C5H3 , H-5), 5.66 (br d, 1 H, NH), 7.11–7.52
(m, 10 H, PPh2). 13C{1H} NMR (CDCl3): d 19.52, 19.61
(CHMe2), 23.24 (MeCO), 29.34 (d, J ¼ 4.9 Hz, CHMe2), 53.70
(CHNH), 64.89 (CH2O), 71.05 (C5H5), 72.53 (C5H3 , C-4),
3
1
75.15 (d, JPC ¼ 1.8 Hz, C5H3 , C-5), 75.28 (d, JPC ¼ 17.4 Hz,
2
C5H3 , C-2), 75.64 (d, JPC ¼ 4.3 Hz, C5H3 , C-3), 77.55 (d,
2JPC ¼ 14.0 Hz, C5H3 , C-1), 128.23 (PPh2 , CHp), 128.35 (d,
3JPC ¼ 7.3 Hz, PPh2 , CHm), 128.39 (d, JPC ¼ 6.1 Hz, PPh2 ,
3
2
CHm), 129.53 (PPh2 , CHp), 131.77 (d, JPC ¼ 17.7 Hz, PPh2 ,
2
3
CHo), 135.29 (d, JPC ¼ 22.0 Hz, PPh2 , CHo), 137.46 (d,
1), 128.02 (PPh2 , CHp), 128.11 (d, JPC ¼ 12.2 Hz, PPh2 ,
1JPC ¼ 11.0 Hz, PPh2 , Cipso), 139.59 (d, 1JPC ¼ 12.2 Hz, PPh2 ,
3
CHm), 128.18 (d, JPC ¼ 12.8 Hz, PPh2 , CHm), 129.13 (PPh2 ,
3
2
Cipso), 169.73 (MeCO), 171.62 (d, JPC ¼ 2.8 Hz, CO2).
CHp), 132.20 (d, JPC ¼ 19.5 Hz, PPh2 , CHo), 135.04 (d,
31P{1H} NMR (CDCl3): d ꢀ14.9 (s). IR (Nujol): v~=cmꢀ1 vNH
1
2JPC ¼ 21.4 Hz, PPh2 , CHo), 137.91 (d, JPC ¼ 12.2 Hz, PPh2 ,
1
3240 (br m), ester vC O 1710 (vs), amide I 1639 (vs), amide
=
Cipso), 139.14 (d, JPC ¼ 11.6 Hz, PPh2 , Cipso), 177.12 (d,
22
II ꢂ 1560 (composite br m). [a]D ¼ ꢀ149.5ꢁ (c ¼ 1.0, CHCl3).
2JPC ¼ 2.4 Hz, CO2H). 31P{1H} NMR (CDCl3): d ꢀ17.4 (s). IR
(Nujol): v~=cmꢀ1 vC O 1712 (m), 1664 (vs). [a]D ¼ ꢀ257.6ꢁ
20
Anal. calcd. for C30H32FeNO3P: C, 66.55; H, 5.96; N, 2.59%.
Found: C, 66.17; H, 6.06; N, 2.57%.
=
(c ¼ 0.99, CHCl3). Anal. calcd. for C23H19FeO2P: C, 66.69; H,
4.62%. Found: C, 66.15; H, 4.71%.
(S,Sp)-2-Acetamido-3-methylbutyl 2-(diphenylphosphinoyl)ferro-
cenecarboxylate, (S,Sp)-3. Ester amide (S,Sp)-2 (108.8 mg, 0.20
mmol) was dissolved in acetone (5 cm3), the solution was
cooled in an ice bath and treated with excess 30% aqueous
hydrogen peroxide (0.5 cm3) for 1 h. Unreacted hydrogen
peroxide was destroyed by addition of 10% aqueous sodium
thiosulfate (1 cm3) and stirring for another 30 min; acetone
was evaporated under reduced pressure and the residue
extracted with CH2Cl2 . The combined organic extracts were
dried with magnesium sulfate and evaporated. The residue was
dissolved in a little hot ethyl acetate and the solution was
allowed to crystallize by hexane diffusion over several days to
give (S,Sp)-3 as fine yellow needles (84.2 mg, 76%).
(Sp)-2-(Diphenylphosphinoyl)ferrocenecarboxylic acid, (Sp)-4.
Aqueous hydrogen peroxide (5 drops of 30% solution) was
added to an ice-cooled solution of (Sp)-Hpfc (42 mg, 0.10
mmol) in acetone (2 cm3) with stirring. After stirring for
another 30 min at 0 ꢁC, excess hydrogen peroxide was
destroyed with 10% aqueous sodium thiosulfate (10 drops)
and stirring for 30 min at room temperature. Acetone was
removed under reduced pressure, and the residue was diluted
with water, acidified with 3 drops of 6 M HCl and extracted
into dichloromethane. The extract was dried over magnesium
sulfate and evaporated to give the phosphine oxide as an
orange yellow solid in quantitative yield (43 mg).
1H NMR (CDCl3): d 4.21 (ddd, J ꢂ 2.6, 2.6, 1.6 Hz, 1 H,
C5H3 , H-3), 4.26 (s, 5 H, C5H5), 4.71 (ddd, J ꢂ 2.6, 2.6, 1.8 Hz,
1 H, C5H3 , H-4), 5.39 (ddd, J ꢂ 2.6, 1.4, 1.4 Hz, 1 H, C5H3 ,
H-5), 7.38–7.92 (m, 10 H, PPh2), 14.07 (s, 1 H, CO2H). 13C{1H}
3
1H NMR (CDCl3): d 1.03, 1.08 (2 Â d, JHH ¼ 6.7 Hz, 3 H,
CHMe2); 1.88 (d of septets, 3JHH ¼ 10.4, 6.7 Hz, 3 H, CHMe2),
2
3
2.13 (s, 3 H, MeCO), 2.94 (dd, JHH ¼ 11.2, JHH ¼ 2.6 Hz, 1
H, CH2O), 3.75 (br dddd, J ꢂ 1.6, 2.6, 10, 10 Hz, 1 H,
CHMe2), 3.79 (ddd, J ꢂ 2.6, 1.3, 1.0 Hz, C5H3 , H-3), 4.49 (s, 5
H, C5H5), 4.58 (ddd, J ꢂ 2.6, 2.6, 0.8 Hz, 1 H, C5H3 , H-4),
1
NMR (CDCl3): d 70.78 (d, JPC ¼ 112 Hz, C5H3 , C-2), 71.51
(d, 2JPC ¼ 13 Hz, C5H3 , C-1), 71.87 (C5H5), 74.18 (d, 3JPC ¼ 11
Hz, C5H3 , C-4), 76.37 (d, 2JPC ¼ 13 Hz, C5H3 , C-3), 76.84 (d,
2
3
5.09 (dd, JHH ¼ 11.2, JHH ¼ 1.6 Hz, 1 H, CH2O), 5.30 (ddd,
J ꢂ 2.6, 1.3, 1.3 Hz, 1 H, C5H3 , H-5), 7.30–7.72 (m, 10 H,
PPh2), 9.11 (d, J ¼ 9.6 Hz, 1 H, NH). 13C{1H} NMR (CDCl3):
d 19.91, 19.96 (CHMe2), 23.32 (MeCO), 29.14 (CHMe2), 54.17
(CHNH), 64.41 (CH2O), 71.45 (C5H5), 72.98 (d, 3JPC ¼ 12 Hz,
3
3JPC ¼ 8 Hz, C5H3 , C-5), 128.73, 128.73 (2 Â d, JPC ¼ 13 Hz,
1
PPh2 , CHm); 129.71 (d, JPC ¼ 111 Hz, PPh2 , Cipso), 131.38,
131.85 (2 Â d, 2JPC ¼ 10 Hz, PPh2 , CHo); 132.21 (d, 1JPC ¼ 107
4
Hz, PPh2 , Cipso), 132.66 (d, JPC ¼ 2 Hz, PPh2 , CHp), 133.07
4
(d, JPC ¼ 3 Hz, PPh2 , CHp), 170.27 (CO2H). 31P{1H} NMR
1
C5H3 , C-4), 73.94 (d, JPC ¼ 81 Hz, C5H3 , C-2), 74.53 (d,
(CDCl3): d 38.3 (s). IR (Nujol): v~=cmꢀ1 vC¼O 1692 (vs).
3
2JPC ¼ 23 Hz, C5H3 , C-1), 76.28 (d, JPC ¼ 8 Hz, C5H3 , C-5),
20
[a]D ¼ ꢀ37.3ꢁ (c ¼ 0.7, CHCl3). Anal. calcd. for
2
80.21 (d, JPC ¼ 15 Hz, C5H3 , C-3), 128.19, 128.31 (2 Â d,
C23H19FeO3P: C, 64.21; H, 4.45%. Found: C, 63.61; H, 4.38%.
2
3JPC ¼ 9 Hz, PPh2 , CHm), 131.15 (d, JPC ¼ 10 Hz, PPh2 ,
4
CHo), 131.70, 131.76 (2 Â d, JPC ¼ 2 Hz, PPh2 , CHp), 131.80
(d, 2JPC ¼ 10 Hz, PPh2 , CHo), 133.61 (d, 1JPC ¼ 110 Hz, PPh2 ,
(RRu ,Sp)-Chloro[2-(diphenylphosphino)ferrocenecarboxylato-
k2O,P]{h6-1-methyl-4-(1-methylethyl)benzene}ruthenium(II),
(RRu ,Sp)-5. (Sp)-Hpfc (44.2 mg, 0.11 mmol) and potassium
1
Cipso), 133.63 (d, JPC ¼ 110 Hz, PPh2 , Cipso), 169.95, 170.11
(CO). 31P{1H} NMR (CDCl3): d 31.8 (s). IR (Nujol): v~=cmꢀ1
572
New J. Chem., 2002, 26, 567–575